Clinical Trials Report Highlights Australia’s Competitive Advantages… And Weaknesses

A new report has found that Australia’s clinical trials sector is large. As international competition for clinical trials intensifies, Australian medtech trade group, MTAA, has pledged to work with industry to overcome impediments to conducting trials in the country.

Business man working on the tablet of the future
Australia's clinical trials sector is large and growing, says a new report • Source: Shutterstock

A new report showing that Australia’s clinical trials sector is large and growing, and that trials involving medical devices grew by 13% between 2010 and 2015, has been welcomed by the country’s medtech industry association, MTAA.

About 1,360 new clinical trials of devices, drugs and other practices were launched in Australia in 2015, according to the government-funded report, which was published last month. This figure has...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

More from Geography

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.